| Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients T Deuse, X Hu, A Gravina, D Wang, G Tediashvili, C De, WO Thayer, ... Nature biotechnology 37 (3), 252-258, 2019 | 563 | 2019 |
| The SIRPα–CD47 immune checkpoint in NK cells T Deuse, X Hu, S Agbor-Enoh, MK Jang, M Alawi, C Saygi, A Gravina, ... Journal of Experimental Medicine 218 (3), e20200839, 2021 | 103 | 2021 |
| De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans T Deuse, X Hu, S Agbor-Enoh, M Koch, MH Spitzer, A Gravina, M Alawi, ... Nature Biotechnology 37 (10), 1137-1144, 2019 | 94 | 2019 |
| Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice T Deuse, G Tediashvili, X Hu, A Gravina, A Tamenang, D Wang, ... Proceedings of the National Academy of Sciences 118 (28), e2022091118, 2021 | 27 | 2021 |
| Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression A Gravina, G Tediashvili, R Rajalingam, Z Quandt, C Deisenroth, ... Nature biotechnology 41 (5), 717-727, 2023 | 19 | 2023 |
| A cryoinjury model to study myocardial infarction in the mouse D Wang, G Tediashvili, X Hu, A Gravina, SG Marcus, H Zhang, JE Olgin, ... JoVE (Journal of Visualized Experiments), e59958, 2019 | 9 | 2019 |
| The HY antigen in embryonic stem cells causes rejection in syngeneic female recipients X Hu, ST Kueppers, NG Kooreman, A Gravina, D Wang, G Tediashvili, ... Stem cells and development 29 (18), 1179-1189, 2020 | 7 | 2020 |
| Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome S Muzumdar, M Koch, H Hiebert, A Bapst, A Gravina, W Bloch, HD Beer, ... Disease models & mechanisms 13 (5), dmm042648, 2020 | 7 | 2020 |
| Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity A Gravina, G Tediashvili, Y Zheng, KA Iwabuchi, SM Peyrot, SZ Roodsari, ... Cell Stem Cell 30 (11), 1538-1548. e4, 2023 | 4 | 2023 |
| Generation of fully immune evasive cell therapeutics A Gravina Staats-und Universitätsbibliothek Hamburg Carl von Ossietzky, 2024 | | 2024 |
| Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. T Deuse, X Hu, A Gravina, D Wang, G Tediashvili, C De, WO Thayer, ... Nature biotechnology 40 (11), 1690, 2022 | | 2022 |
| CRIPSR/Cas9 Technology: Hypoimmunogenic Pluripotent Stem Cells Evade Immune Rejection in Fully Immunocompetent Allogeneic Recipients X Hu, T Deuse, A Gravina, D Wang, G Tediashvili, H Reichenspurner, ... The Journal of Heart and Lung Transplantation 40 (4), S28-S29, 2021 | | 2021 |
| HYPOIMMUNOGENIC DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS EVADE X Hu, T Deuse, A Gravina Transplantation 104, S3, 2020 | | 2020 |
| De Novo Mutations in Mitochondrial DNA of iPSCs Produce Immunogenic Neoepitopes in Humans A Gravina, T Deuse, X Hu, S Agbor-Enoh, M Koch, M Alawi, A Marishta, ... The Journal of Heart and Lung Transplantation 39 (4), S23, 2020 | | 2020 |
| Hypoimmunogenic Derivatives of Induced Pluripotent Stem Cells Evade Immune T Deuse, X Hu, A Gravina | | 2020 |
